These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hypercholesterolemia: a reversible risk factor for coronary heart disease. Mishkel MA CMAJ; 1989 Feb; 140(4):419. PubMed ID: 2644008 [No Abstract] [Full Text] [Related]
3. The special cholesterol concerns of women. Johns Hopkins Med Lett Health After 50; 2000 Sep; 12(7):4-5. PubMed ID: 10948881 [No Abstract] [Full Text] [Related]
4. [Cholesterol--the main risk factor in ischemic heart disease]. Heyden S; Kroos S Schweiz Rundsch Med Prax; 1988 Nov; 77(48):1312-7. PubMed ID: 3064242 [No Abstract] [Full Text] [Related]
5. Your cholesterol might have to come down--way down. Comarow A US News World Rep; 2001 May; 130(21):46-8. PubMed ID: 11383131 [No Abstract] [Full Text] [Related]
6. Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease. Nag SS; Pearson TA; Ma L; Landsman PB; Cimino A; Vickers FF; Alexander CM; Melin JM Am J Cardiol; 2005 Apr; 95(7):862-4. PubMed ID: 15781017 [TBL] [Abstract][Full Text] [Related]
7. The heart of the matter. National guidelines urge more aggressive cholesterol treatment. Leake NB Adv Nurse Pract; 2002 Jan; 10(1):42-7; quiz 48-9. PubMed ID: 12420511 [No Abstract] [Full Text] [Related]
8. Treating hypercholesterolemia. How should practicing physicians interpret the published data for patients? Brett AS N Engl J Med; 1989 Sep; 321(10):676-80. PubMed ID: 2519528 [No Abstract] [Full Text] [Related]
9. Cholesterol and coronary heart disease: screening and treatment. Ebrahim S; Smith GD; McCabe C; Payne N; Pickin M; Sheldon TA; Lampe F; Sampson F; Ward S; Wannamthee G Qual Health Care; 1998 Dec; 7(4):232-9. PubMed ID: 10339027 [No Abstract] [Full Text] [Related]
10. Hypercholesterolemia. Is lipid-lowering worthwhile for older patients? Deedwania PC Geriatrics; 2000 May; 55(5):22-8. PubMed ID: 10826262 [TBL] [Abstract][Full Text] [Related]
11. [The role of cholesterol-lowering drugs in prevention of coronary heart disease]. SkaĆuba Z; Undas R Przegl Lek; 1998; 55(7-8):382-7. PubMed ID: 10021881 [TBL] [Abstract][Full Text] [Related]
16. Introduction: missing the target with lipid-lowering therapy. Hunninghake DB; McKenney JM Am J Manag Care; 2000 Nov; 6(19 Suppl):S992-6. PubMed ID: 11187370 [No Abstract] [Full Text] [Related]
17. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS). Lim PO; Yee KM Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109 [No Abstract] [Full Text] [Related]
18. Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study). Garmendia F; Brown AS; Reiber I; Adams PC Curr Med Res Opin; 2000; 16(3):208-19. PubMed ID: 11191012 [TBL] [Abstract][Full Text] [Related]
19. Women, the media, and heart disease. For better or for worse? Savoie I; Kazanjian A; Brunger F Int J Technol Assess Health Care; 1999; 15(4):729-37. PubMed ID: 10645114 [TBL] [Abstract][Full Text] [Related]
20. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly]. MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640 [No Abstract] [Full Text] [Related] [Next] [New Search]